Related Experiment Video

Updated: Jul 20, 2026

A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
10:12

A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model

Published on: October 31, 2012

Gene therapy for pulmonary diseases

Martin Kolb1, Gail Martin, Maria Medina

  • 1Centre for Gene Therapeutics, Department of Pathology and Molecular Medicine, McMaster University, 1200 Main St W, Hamilton, ON, Canada L8N 3Z5.

Chest
|September 12, 2006
PubMed

Insights

Gene therapy shows promise for lung diseases, including cystic fibrosis and cancer. Recent advances focus on improving gene transfer for better clinical applications.

Area of Science:

  • Pulmonology
  • Genetics
  • Biotechnology

Background:

  • Gene therapy's potential for lung diseases remains high despite early challenges.
  • Lung diseases like cystic fibrosis, cancer, and chronic inflammatory conditions are targets for gene therapy.
  • Therapeutic strategies aim to correct genetic defects or rebalance cellular mechanisms.

Purpose of the Study:

  • To review recent advancements in gene transfer technologies for lung diseases.
  • To highlight current and emerging clinical applications of gene therapy in pulmonology.
  • To provide an overview of the evolving landscape of gene therapy for respiratory conditions.

Main Methods:

  • Literature review of recent studies on gene transfer systems.
  • Analysis of preclinical and clinical data for gene therapy in lung diseases.
  • Synthesis of information on novel gene delivery vectors and therapeutic strategies.

Main Results:

  • Significant progress has been made in developing more efficient gene transfer systems.
  • Gene therapy is being explored for single-gene disorders (e.g., cystic fibrosis) and complex diseases (e.g., lung cancer).
  • Emerging data suggest potential efficacy in addressing the underlying mechanisms of various lung pathologies.

Conclusions:

  • Gene therapy is a rapidly advancing field with considerable potential for treating diverse lung diseases.
  • Continued innovation in gene delivery is crucial for realizing the full therapeutic benefits.
  • Gene therapy offers a promising frontier for managing conditions previously considered intractable.

More Related Videos

Protein Transfection of Mouse Lung04:21

Protein Transfection of Mouse Lung

Published on: May 15, 2013

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...